You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 124 No. 1, July 1969 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Arrhythmias in Myocardial Infarction

LT Douglas P. Zipes, MC

Arch Intern Med. 1969;124(1):101-109.


Abstract



More than 90% of the patients with acute myocardial infarction experience some type of arrhythmia. Premature venticular systoles occur most often, and lidocaine is preferred for initial drug therapy. For symptomatic ventricular tachycardia and for ventricular flutter or fibrillation, immediate direct current cardioversion is mandatory. The most important therapeutic aspect of supraventricular arrhythmias is control of the ventricular rate. Rapid rates must be slowed by atrial pacing, direct current cardioversion, or the administration of digitalis. Bradycardias may lead to ectopic beating and should be treated with atropine sulfate, isoproterenol hydrochloride, and artificial pacing if necessary. In patients with atrioventricular (AV) block, the differentiation between Mobitz type 1 and Mobitz type 2 is essential since the latter frequently requires transvenous pacing while the former resolves spontaneously and the problems associated with temporary transvenous pacing may be avoided.



Author Affiliations



USNR, Portsmouth, Va


Footnotes



Received for publication Dec 6, 1968; accepted Jan 31, 1969.

From the Cardiopulmonary Laboratory, Department of Medicine, Naval Hospital, Portsmouth, Va. Part of this study was performed while the author was with the Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC.

The opinions or assertions contained herein are those of the author and are not to be construed as official or reflecting the views of the Navy Department or of the naval service at large.

Reprint requests to Cardiopulmonary Laboratory, Naval Hospital, Portsmouth, Va 23708 (LT Zipes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.